Literature DB >> 11040886

Substance misuse as a marker of vulnerability among male prisoners on remand.

D Brooke1, C Taylor, J Gunn, A Maden.   

Abstract

BACKGROUND: More treatment for substance misuse should be provided within prisons. AIMS: To examine differences between prisoners on remand with substance misuse problems and other prisoners on remand.
METHOD: Random selection and interview of unconvicted male prisoners (n = 750, a 9.4% sample), plus examination of the prison medical record.
RESULTS: Of the sample of 750, 253 subjects (33.7%) reported either drug- or alcohol-related health problems or dependency. Compared with other prisoners on remand, they reported more childhood adversity, conduct disorder, self-harm, past psychiatric treatment and current mood disorder, and had fewer qualifications, were more likely to be unemployed and have more housing difficulties.
CONCLUSIONS: One-third of unconvicted men in prison report substance-related problems, and these are a marker for vulnerability within a disadvantaged population. Health care providers should involve this group in treatment and rehabilitation, both inside prison and following release.

Entities:  

Mesh:

Year:  2000        PMID: 11040886     DOI: 10.1192/bjp.177.3.248

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Socioeconomic factors associated with drug consumption in prison population in Mexico.

Authors:  Armando Nevárez-Sida; Patricia Constantino-Casas; Angélica Castro-Ríos
Journal:  BMC Public Health       Date:  2012-01-13       Impact factor: 3.295

2.  Prevalence and factors associated with alcohol and drug-related disorders in prison: a French national study.

Authors:  Michael Lukasiewicz; Bruno Falissard; Laurent Michel; Xavier Neveu; Michel Reynaud; Isabelle Gasquet
Journal:  Subst Abuse Treat Prev Policy       Date:  2007-01-04

3.  Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.

Authors:  John Strang; Sheila M Bird; Mahesh K B Parmar
Journal:  J Urban Health       Date:  2013-10       Impact factor: 3.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.